NIH-funded research R01 grant

Understanding how autism risk genes affect brain development using zebrafish

Official title: High-throughput Functional Analysis of Autism Risk Genes

Funded at Yale University · NIH-11408569 · Data updated 2026-11-12

Researchers are testing how autism risk genes influence brain development by studying them in zebrafish and human stem cells to uncover shared harmful pathways.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startMarch 1, 2018
Project endJune 30, 2029
Funding year2026
Award (this year)$740,702
NIH project number5R01MH116002-08
Project IDNIH-11408569 on NIH RePORTER

Who could benefit from this research

Could help

Patients with autism spectrum disorder who may benefit from advances in understanding gene-related brain mechanisms could be future trial candidates or participants in related translational studies.

Less likely to help

Direct patient treatment is not part of this basic mechanistic study and may not provide immediate clinical benefits.

What this research studies

This project uses a high-throughput zebrafish system to study dozens of autism-related genes at once, looking for common cellular and brain circuit changes. It will compare results from fish models to human stem cell-derived neurons to find conserved mechanisms. The goal is to map molecular signatures and identify potential targets for therapies that could benefit people with autism spectrum disorder. The study builds on prior work showing convergent gene effects and aims to reveal how disruption of these genes shapes brain structure and activity.

Why it matters

Potential benefit: If successful, the work could identify shared pathways and targets for new treatments that address core brain mechanisms in autism.

How similar studies have gone: Prior work demonstrated convergent effects of ASD genes in zebrafish; expanding to 50 genes in parallel is a logical progression with strong justification.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Hoffman, Ellen J — Yale University
  • Study coordinator: Hoffman, Ellen J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.